Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
The Journal of Antibiotics|April 3, 2014
Effect of linezolid on hematological and oxidative parameters in ratsTianlin Wang, Daihong Guo, Xianzhe Dong, et al.
Neurological Research|May 31, 2012
Preparation and evaluation of NGF-microsphere conduits for regeneration of defective nervesHuayan Sun, Fenghua Xu, Daihong Guo, et al.
Drug Development and Industrial Pharmacy|April 10, 2013
In vitro evaluation of the effects of various additives and polymers on nerve growth factor microspheresHuayan Sun, Fenghua Xu, Daihong Guo, et al.
British Journal of Clinical Pharmacology|May 5, 2021
Incidence, characteristics and risk factors for drug-induced liver injury in hospitalized patients: A matched case-control studyXianghao Kong, Daihong Guo, Siyuan Liu, et al.
Pharmacology|October 21, 2021
A Risk-Prediction Nomogram for Neutropenia or Febrile Neutropenia after Etoposide-Based Chemotherapy in Cancer Patients: A Retrospective Cohort StudyYu Zhu, Daihong Guo, Xianghao Kong, et al.
Expert Opinion on Drug Safety|April 26, 2025
Incidence, clinical characteristics and related drugs analyzing of drug-induced movement disorders in 102914 inpatients: a retrospective real-world studyLiqiang Cui, Daihong Guo, Man Zhu, et al.
Frontiers in Pharmacology|July 1, 2021
Development and Validation of a Nomogram for Predicting Drug-Induced Acute Kidney Injury in Hospitalized Patients: A Case-Control Study Based on Propensity-Score MatchingChengxuan Yu, Daihong Guo, Chong Yao, et al.
European Journal of Clinical Pharmacology|January 3, 2026
Construction and temporal external validation of interpretable machine-learning models for predicting tigecycline-associated hypofibrinogenemiaAn Fu, Daihong Guo, Man Zhu, et al.
International Journal of Clinical Pharmacy|January 31, 2025
Pharmacovigilance analysis of drug-induced hypofibrinogenemia using the FDA Adverse Event Reporting SystemXiao Wen, Le Cai, Ao Gao, et al.
European Journal of Clinical Pharmacology|March 5, 2024
Incidence, characteristics, and risk factors of drug-associated muscle adverse reaction: a retrospective real-world study of inpatientsAnqi Zhao, Daihong Guo, Man Zhu, et al.
Pageof 3